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Abstract
Objective To assess the performance of hybrid (HIR) and
model-based iterative reconstruction (MIR) in patients with
urolithiasis at reduced-dose computed tomography (CT).
Methods Twenty patients scheduled for unenhanced abdomi-
nal CT for follow-up of urolithiasis were prospectively includ-
ed. Routine dose acquisition was followed by three low-dose
acquisitions at 40%, 60% and 80% reduced doses. All images
were reconstructed with filtered back projection (FBP), HIR
and MIR. Urolithiasis detection rates, gall bladder, appendix
and rectosigmoid evaluation and overall subjective image
quality were evaluated by two observers.
Results 74 stones were present in 17 patients. Half the stones
were not detected on FBP at the lowest dose level, but this
improved withMIR to a sensitivity of 100%. HIR resulted in a
slight decrease in sensitivity at the lowest dose to 72%, but
outperformed FBP. Evaluation of other structures with HIR at
40% and withMIR at 60% dose reductions was comparable to
FBP at routine dose, but 80% dose reduction resulted in non-
evaluable images.
Conclusions CT radiation dose for urolithiasis detection can
be safely reduced by 40 (HIR)–60 (MIR) % without affecting
assessment of urolithiasis, possible extra-urinary tract pathol-
ogy or overall image quality.
Key Points
• Iterative reconstruction can be used to substantially lower
the radiation dose.
• This allows for radiation reduction without affecting sensi-
tivity of stone detection.
• Possible extra-urinary tract pathology evaluation is feasible
at 40–60% reduced dose.
Keywords Urolithiasis . Multidetector computed
tomography . Radiation ionising . Sensitivity . Imaging .
Diagnostic
Abbreviations
CT Computed tomography
CTDIvol Volumetric CT dose index
DLP Dose length product
FBP Filtered back projection
HIR Hybrid iterative reconstruction
HU Hounsfield unit
ICC Intraclass correlation coefficient
IQR Interquartile range
IR Iterative reconstruction
MIR Model-based iterative reconstruction
ROI Region of interest
SD Standard deviation
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Introduction
The most frequent cause of acute flank pain is urolithiasis,
which affects 3–5% of the population [1]. The risk of recur-
rence of urolithiasis is high, with 50% after 5 years and more
than 72% after 20 years [2]. In the USA, the total estimated
annual cost for stone disease was over US$10.3 billion in
2006, an almost fivefold increase in 6 years [3]. This rise is
still present today. Unenhanced computed tomography (CT) is
often used for the diagnosis of urolithiasis. Compared to ul-
trasonography, CToffers the possibility to detect extra-urinary
causes of flank pain [1], and has a higher specificity and sen-
sitivity. The guidelines of the European Association of
Urology [4] as well as the American College of Radiology
[5] advise using low-dose CT in patients with acute disease
and suspicion of urolithiasis, while the American Urological
Association provides no clear recommendation [6]. However,
CT suffers from several disadvantages such as higher costs
compared to ultrasonography, limited availability in develop-
ing countries and the associated exposure to ionising radia-
tion. Technical advancements like iterative reconstruction (IR)
algorithms have resulted in substantial radiation dose reduc-
tions. IR results in reduced noise, allowing acquisition of im-
ages at reduced radiation dose levels without intrinsically
hampering image quality. Several studies have investigated
the potential of IR for unenhanced abdominal CT, with most
studies focusing on urinary stone detection and image quality
[7–10]. The purpose of this study was to assess the perfor-
mance of hybrid IR (HIR) and model-based IR (MIR) in pa-
tients with urolithiasis at reduced-dose CT.
Materials and methods
This prospective study was approved by our local institutional
review board (NL46146.041.13). Inclusion criteria were: pa-
tient age of ≥40 years and a scheduled unenhanced abdominal
CT for follow-up of urolithiasis. Patients with concomitant
participation in another study with x-ray exposure were ex-
cluded. All patients were informed about the additional radi-
ation exposure and provided written informed consent.
Gender, age, height and weight of all patients were recorded.
Twenty patients were included between April 2014 and
October 2015.
CTacquisition
All acquisitions were performed on a 256-slice CT system
(Brilliance iCT, Philips Healthcare, Best, The Netherlands).
The routine dose acquisition was followed by three low-dose
acquisitions with the same scan length during the same ses-
sion. A tube voltage of 120 kVp was used for all acquisitions.
To create different dose levels, the tube current was lowered.
All patients were imaged with automatic exposure control
using a reference of 100 mAs (routine dose) and 60, 40 and
20 mAs (reduced dose levels), respectively. The pitch was
0.915 with a rotation time of 0.4 s. Slices were reconstructed
with a thickness of 0.9 mm and increment of 0.7 mm for all
measurements. All acquisitions were reconstructed with fil-
tered back projection (FBP), HIR (iDose4 level 4, Philips
Healthcare) and MIR (IMR level 2, Philips Healthcare). The
routinely used kernel B was used for FBP and iDose4 recon-
structions. IMR has three groups of kernels, namely Body Soft
Tissue, Body Routine and Body SharpPlus [11]. Both Body
Soft Tissue and Body Routine are recommended by the ven-
dor for soft tissue evaluation, and were therefore both used.
Dose length product (DLP) and volumetric CT dose index
(CTDIvol) were recorded for each scan. The effective dose
was calculated by multiplying the DLP with the conversion
factor for 120 kV abdominal acquisitions (0.0153 mSv/
(mGy×cm)) [12].
Image evaluation
All FBP acquisitions at routine dose were assessed to set the
reference for the number and location of the stones.
Urolithiasis was classified as stones (kidney, ureter or blad-
der), papillary calcifications or parenchymal calcifications.
The reference evaluation was done by a certified board radi-
ologist (PJ) with over 10 years of experience in abdominal
radiology. This radiologist was not an observer in the current
study. The maximal size of all stones was measured in three
planes (transversal, coronal and sagittal) using the routine
dose acquisition reconstructed with FBP and the average max-
imal diameter was calculated [13]. Subsequently, two ob-
servers (FW and PD) with more than 5 years of experience
in abdominal radiology assessed the number of stones on all
acquisitions and reconstructions.
Subjective image quality was assessed by the same two
observers who were blinded for patient characteristics, acqui-
sition and reconstruction information, and images were eval-
uated in randomised order. Overall image quality was scored
using a 4-point Likert scale:
& Score 1: poor image quality – not diagnostically accept-
able for interpretation;
& Score 2: suboptimal image quality – partially non-
diagnostic;
& Score 3: acceptable image quality – diagnostic interpreta-
tion possible;
& Score 4: excellent image quality.
A score of 1–2 was considered unacceptable. One patient
was used as a test case and used for training in a consensus
meeting. Because it is important to be able to diagnose extra-
urinary tract pathology, several other aspects were scored as
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well. Observers were asked to assess if there was a prior cho-
lecystectomy, or, if the gall bladder was still present, it was
assessed for the presence stones or wall thickening, or whether
these could have been visualized if present. The maximal
infra-renal diameter of the aorta was assessed in the anterior-
posterior direction for abdominal aneurysm evaluation. The
sigmoid and appendix were evaluated to see if there were
signs of diverticulitis or appendicitis, or whether these could
have been visualized if present. The maximal width of the
body of the adrenal gland was assessed on the transversal
plane, and the average Hounsfield unit (HU) was derived by
drawing a circular region of interest (ROI) as large as possible.
Objective image quality was measured by drawing a circu-
lar ROI in the renal cortex (both left and right), aorta, retro-
peritoneal fat and air in the bowel. Noise was defined as the
standard deviation (SD) of the HU measurement in the ROI.
Statistical analysis
Statistical analyses were performed using SPSS (version 20.0,
IBM, New York, USA). The test case was excluded from
further analysis. FBP at routine dose was used as a reference
standard, and all data were compared to the reference stan-
dard. To assess the subjective overall image quality the scores
of the two observers were averaged. Also, the number of un-
acceptable scans (score 1 or 2) was calculated per observer.
Sensitivity for the detection of stones was calculated by divid-
ing the number of correctly identified stones by the total num-
ber of stones and multiplying this number by 100%. The sen-
sitivity as well as the number of false positives was calculated
both on a patient level and overall. In the per-patient level
analysis, the number of false positives and the sensitivity were
calculated for each patient separately. Therefore, missing a
stone in a patient with only 1 stone will have a heavier weight
than missing a stone in a patient with multiple stones. In the
overall analysis the total number of false positives for all pa-
tients combined was calculated per observer, as well as the
overall sensitivity. In this analysis, each stone has an equal
weight.
Data were compared using the Friedman test and post-hoc
analyses were performed using the Wilcoxon signed rank test.
A p-value below 0.05 was considered significant. For the
post-hoc tests a Bonferroni corrected p-value of 0.0125 was
used. Values are presented as medians (interquartile range,
IQR) unless stated otherwise.
Interobserver agreement was measured using Cohen’s kap-
pa coefficient and the percentage of agreement for categorical
variables. The kappa was interpreted as poor (0.00 ≤ k ≤ 0.20),
fair (0.21 ≤ k ≤ 0.40), moderate (0.41 ≤ k ≤ 0.60), good (0.61 ≤
k ≤ 0.80) or excellent (0.81 ≤ k ≤ 1.00). For categorical vari-
ables with more than two categories a weighted kappa was
used. A two-way random intraclass correlation coefficient
(ICC) was used for continuous parameters, as well as the
difference (in mm or HU).
Results
A total of 20 patients were included, of which one patient was
used as a test case for the consensus meeting. Therefore, ulti-
mately 19 patients were investigated: 16 males (16/19, 84%)
and three females (3/19, 16%). The median age was 61 (IQR
52–67) years. Mean height was 181 (172–189) cm with a
weight of 86 (75–100) kg resulting in a body mass index
(BMI) of 25.6 (25.0–32.4) kg/m2.
Effective dose was 4.8 (4.1–7.8) mSv at routine dose and
2.8 (2.5–4.7), 1.9 (1.6–3.1) and 0.9 (0.8–1.5) mSv at reduced
dose levels, respectively. CTDIvol was 6.6 (5.5–10.5), 3.9
(3.3–6.3), 2.6 (2.2–4.2) and 1.3 (1.1–2.1) mGy, respectively,
while the DLP was 312 (270–508) mGy*cm at routine dose
and 184 (162–304), 123 (106–204) and 60 (51–99) mGy*cm
at reduced dose levels, respectively.
Diagnostic performance for stones and calcifications
In total 74 stones were present in 17 patients, including 63
stones, seven papillary calcifications and four parenchymal
calcifications (Table 1). Of the 63 stones, 62 were in the kid-
ney and one in the ureter. The size of the stones was smaller
than 3 mm (19/74, 26%), 3–5 mm (26/74, 35%), 5–10 mm
(21/74, 28%) or larger than 10 mm (8/74, 11%).
The accuracy of stone detection is shown in Table 2. The
sensitivity at routine dose was 94% with FBP, because some
stones were missed by a single observer. The sensitivity at
routine dose with IR was 100%. At reduced dose, the sensi-
tivity with FBP decreased to 89%, 88% and 50%, respectively.
While with HIR the sensitivity was 100%, 89% and 72%,
respectively. MIR Body Routine resulted in a sensitivity of
100% at all dose levels while the sensitivity with MIR Soft
Tissue reduced to 79% at the lowest dose level. An example of
decreased sensitivity is provided in Fig. 1. All missed stones
concerned stones with a size below 3mm. The number of false
positives was low at all dose levels with a median number
between 0 and 1. The overall sensitivity is presented in
Table A in the Appendix.
Extra-urinary tract pathology
Results of the assessment of extra-urinary tract pathology are
displayed in Table 2. At routine dose reconstructed with FBP,
the assessment of prior cholecystectomy and sigmoid diver-
ticulitis was possible in all patients. Gall bladder assessment
for stones and for wall thickening was hampered in one patient
(5%) and one or eight patients (5% or 42%), respectively,
depending on the observer. One observer also scored the
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appendix as not assessable (one patient, 5%) or as inflamma-
tory signs not assessable (two patients, 11%). The assessment
of prior cholecystectomy and sigmoid diverticulitis was pos-
sible up to 60% reduced dose with FBP, while with HIR and
MIR the dose could be decreased by 80%. Gall bladder stones
were still assessable at 60% reduced dose with both MIR
kernels, and at 80% dose using MIR Soft Tissue. The assess-
ment of gall bladder wall thickening was similar to the refer-
ence at 40% reduced dose usingMIR (both kernels).While for
the assessment of the appendix the dose could be reduced by
40% for HIR and by 60% using MIR (both kernels). Overall,
40% dose reduction with HIR and 60% dose reduction with
MIR yielded similar results to the reference (routine dose with
FBP).
The aorta and adrenal gland measurements did not show
any significant differences at reduced dose (Appendix,
Table B). However, with FBP the adrenal glands were not
always assessable at all reduced dose levels, while at 60%
dose reduced-dose HIR resulted in not assessable reconstruc-
tions as well. At the lowest dose level, the adrenal gland was
not assessable in several patients on all reconstruction
methods (Appendix, Table B).
Table 2 Diagnostic performance. The sensitivity for stone detection
was calculated on a patient level, and stones, papillary calcifications
and parenchymal calcifications were combined. Two patients did not
have any stones. The sensitivity is presented as median (interquartile).
For the assessment of extra-urinary tract pathology the number [percent-
age] of non-assessable reconstructions is displayed per observer
Sensitivity Cholecys-
tectomy
Gall bladder
stones
Gall bladder wall
thickening
Sigmoid
diverticulitis
Appendix
visible
Appendicitis
Routine dose Obs. 1 Obs. 2 Obs. 1 Obs. 2 Obs. 1 Obs. 2 Obs. 1 Obs. 2 Obs. 1 Obs. 2 Obs. 1 Obs. 2
FBP 94.4 (80.0–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 8 [42] 0 [0] 0 [0] 0 [0] 1 [5] 0 [0] 2 [11]
HIR 100.0 (80.0–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 2 [11] 2 [11] 0 [0] 0 [0] 0 [0] 1 [5] 0 [0] 1 [5]
MIR (BR) 100.0 (92.9–100.0) 0 [0] 0 [0] 0 [0] 1 [5] 0 [0] 3 [16] 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 1 [5]
MIR (ST) 100.0 (77.8–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 2 [11] 0 [0] 0 [0] 2 [11] 1 [5] 1 [5] 2 [11]
40% reduced dose
FBP 88.9 (50.0–100.0) 0 [0] 0 [0] 1 [5] 2 [11] 4 [21] 16 [84] 0 [0] 0 [0] 0 [0] 2 [11] 0 [0] 3 [16]
HIR 100.0 (80.0–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 4 [21] 8 [42] 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 2 [11]
MIR (BR) 100.0 (92.9–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 4 [21] 0 [0] 0 [0] 0 [0] 1 [5] 0 [0] 2 [11]
MIR (ST) 100.0 (92.9–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 1 [5] 5 [26] 0 [0] 0 [0] 1 [5] 0 [0] 2 [5] 2 [11]
60% reduced dose
FBP 87.5 (50.0–100.0) 0 [0] 0 [0] 2 [11] 5 [26] 7 [37] 19 [100] 0 [0] 0 [0] 2 [11] 4 [21] 4 [21] 5 [26]
HIR 88.9 (75.0–100.0) 0 [0] 0 [0] 1 [5] 2 [11] 5 [26] 13 [68] 0 [0] 0 [0] 1 [5] 1 [5] 0 [0] 5 [26]
MIR (BR) 100.0 (81.3–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 2 [11] 8 [42] 0 [0] 0 [0] 0 [0] 1 [5] 0 [0] 1 [5]
MIR (ST) 100.0 (80.0–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 3 [16] 4 [21] 1 [5] 0 [0] 1 [5] 1 [5] 1 [5] 1 [5]
80% reduced dose
FBP 50.0 (16.7–100.0) 1 [5] 3 [15] 14 [74] 14 [74] 18 [95] 10 [100] 17 [90] 8 [42] 16 [84] 16 [84] 18 [95] 16 [84]
HIR 72.2 (62.5–100.0) 0 [0] 0 [0] 4 [21] 6 [32] 11 [58] 18 [95] 1 [5] 0 [0] 6 [32] 3 [16] 4 [21] 6 [32]
MIR (BR) 100.0 (68.8–100.0) 0 [0] 0 [0] 2 [11] 3 [16] 4 [21] 9 [47] 1 [5] 0 [0] 1 [5] 1 [5] 1 [5] 4 [21]
MIR (ST) 78.6 (50.0–100.0) 0 [0] 0 [0] 1 [5] 1 [5] 4 [21] 11 [58] 0 [0] 0 [0] 0 [0] 2 [11] 2 [11] 2 [11]
FBP filtered back projection, HIR hybrid iterative reconstruction, MIR model-based iterative reconstruction, BR body routine, ST soft tissue, Obs
observer
Table 1 Stone and calcification characteristics
Diameter Total
<3 mm 3–5 mm 5–10 mm >10 mm
n Density (HU) n Density (HU) n Density (HU) n Density (HU)
Stone 16 307 (251–371) 23 365 (323–531) 16 720 (541–897) 8 822 (665–982) 63
Papillary calcification 2 333 (257–333) 1 335 4 837 (645–1237) 0 NA 7
Parenchymal calcification 1 481 2 312 (258–312) 1 694 0 NA 4
Total 19 26 21 8 74
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Observer agreement for subjective parameters was moder-
ate to excellent, except for gallbladder wall thickening with a
kappa of 0.31. The ICC was excellent for measuring the di-
ameter of the aorta (ICC 0.95), and poor to fair for the adrenal
glandmeasurements. Differences between observers were low
with a mean difference of 1.2 and 0.2 mm and 3.9 and 7.5 HU
for the left and right adrenal gland respectively. Results are
also shown in the Appendix, Table C.
Image quality
An example of the different subjective image quality scores is
provided in Fig. 2. An additional example can be found in the
Appendix, Figure A. The image quality scores are provided in
Table 3. The median image quality score at routine dose
reconstructed with FBP was 3 (acceptable image quality).
One observer scored all scans at routine dose as acceptable
image quality, while the other observer scored nine patients
(47%) as having unacceptable image quality. HIR, MIR Body
Routine and MIR Soft Tissue resulted in significantly higher
subjective image quality scores of 4 on routine dose. In addi-
tion, the number of patients with unacceptable image quality
decreased to one (5%) with HIR and to zero with both MIR
kernels. With FBP the image quality significantly decreased at
the two lowest dose levels. At the lowest dose level, the image
quality was unacceptable in all patients with FBP. At 40% and
60% reduced dose, IR resulted in similar or improved image
quality compared to the reference acquisition (FBP at routine
dose). While at the lowest dose level, the image quality sig-
nificantly decreased with all reconstruction techniques;
Fig. 1 Example of decreased
sensitivity for stone detection.
From left to right the stone at
routine dose reconstructed with
FBP (a), the FBP reconstruction
at the lowest dose level on which
the stone was missed (b) and the
IR reconstructions (HIR, MIR
Body Routine and MIR Soft
Tissue) at the same dose level on
which the stone is clearly visible
Fig. 2 Example of the subjective image quality score. From left to right
the different scores: score 1 with FBP at 80% reduced dose, score 2 with
HIR at 80% reduced dose, score 3 with MIR Soft Tissue at 60% reduced
dose and score 4 with HIR at the routine dose level. Note that the kidney
stone can be seen in all images. Score 1 was mainly because of excessive
noise. Score 2 was also due to substantial noise. Score 3 was given
because of smoothening by IR. Score 4 contains some noise, but
radiologists are used to some noise and tend to prefer this to extensive
smoothening and noise reduction
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however, the image quality was still better with HIR (2) and
MIR (3) compared to FBP (1).
Overall agreement for subjective image quality was mod-
erate with a weighted kappa of 0.59. The percentage of total
agreement was 47%. In 4.3% of comparisons there was more
than 1 point difference in the subjective image quality score
between observers.
Noise and attenuation are presented in Table 3 and in the
supplemental files in the Appendix (Table D, Fig. B-C). At
routine dose, both HIR and MIR resulted in a reduction in
noise. Reducing the radiation dose led to a significant increase
in noise with FBP, while MIR resulted in a decrease in noise
compared to FBP at routine dose, even at 80% reduced dose.
With a 40% or 60% reduction in dose, HIR resulted in less
noise compared to FBP at routine dose, while at 80% reduced
dose the amount of noise was comparable to FBP at routine
dose.
Mean densities were not affected by dose reduction, except
for the lowest dose level and the density of air. This resulted in
a slightly higher attenuation.
Discussion
This prospective, within-patient study showed that the radia-
tion dose can be reduced by 40% (to median 3.8 mGy) using
HIR and by 60% (to median 2.6 mGy) using MIR in CTscans
for urolithiasis evaluation in patients with a median weight of
86 kg and a BMI range from 20 to 39 kg/m2. Sensitivity for
stones remained excellent at 60% reduced dose with IR while
sensitivity decreased with low-dose FBP. At these low-dose
levels, extra-urinary tract pathology was still assessable with
IR, while objective and subjective image quality improved
compared to FBP at routine dose. Further dose reduction ham-
pered the diagnosis of extra-urinary tract pathology and is
therefore not advised with current reconstruction methods.
Current guidelines recommend the use of low-dose CT in
patients suspected of urolithiasis [4, 6]. The definition of low
dose is not unambiguous, but a dose below 3 mSv is usually
considered a low dose for native abdominal CT for follow-up
of urolithiasis [14]. A large survey study performed in 93
hospitals in the USA between 2011 and 2013 including
49,903 renal colic CT examinations reported a mean radiation
dose of 11.2 mSv (14.3 mGy) in clinical practice [15]. Only
2% of those examinations were performed at a low dose (<3
mSv) and 0.2% at a dose below 2 mSv. The high contrast
between stones and the surrounding soft tissue should make
it possible to substantially reduce the radiation dose without
affecting diagnostic accuracy, and various studies have shown
that the radiation dose for urinary stone CTacquisitions can be
safely reduced below 3 mSv without affecting the diagnostic
accuracy of stone detection [16]. One of the largest studies
(201 patients) was performed by Moore and colleagues [8].
Patients suspected of ureteral stones received both a routine
Table 3 Subjective image quality and noise per reconstruction method
and per dose level. For the image quality, the average score of the two
observers was used. Those data are presented as median [interquartiles].
Also, the number of examinations [%] with unacceptable image quality
(score 1 or 2) is shown per observer. The noise is presented as medians
(interquartiles)
Subjective
image
quality
Unacceptable
image quality
Renal cortex
(right)
Renal cortex
(left)
Aorta Retroperitoneal
fat
Air
Routine dose Obs. 1 Obs. 2
FBP 3 [3–3] 0 [0] 9 [47] 53.3 (48.6–61.2)
Reference
51.8 (42.8–60.0)
Reference
56.5 (50.3–68.8)
Reference
54.7 (45.7–61.4)
Reference
23.5 (22.4–26.3)
Reference
iDose4 4 [4–4]* 0 [0] 1 [5] 32.2 (29.0–37.1)* 32.4 (28.5–36.1)* 37.4 (30.8–42.0)* 35.6 (29.6–37.3)* 17.7 (16.9–17.7)*
MIR (BR) 4 [4–4]* 0 [0] 0 [0] 10.2 (9.5–11.6)* 11.5 (10.0–12.3)* 11.7 (10.0–13.6)* 13.0 (11.4–14.8)* 6.6 (5.7–7.3)*
MIR (ST) 4 [4–4]* 0 [0] 0 [0] 7.2 (6.2–8.2)* 7.5 (7.0–8.0)* 7.7 (6.0–9.5)* 9.1 (7.6–10.9)* 4.2 (4.0–7.3)*
40% reduced dose
FBP 3 [3–3] 3 [16] 15 [79] 70.0 (62.8–83.5)* 72.2 (63.5–79.3)* 77.3 (69.6–97.0)* 74.8 (55.6–83.8)* 31.7 (25.9–37.7)*
iDose4 3 [3–4] 0 [0] 8 [42] 37.8 (34.6–39.7)* 38.0 (34.2–42.4)* 44.0 (37.7–45.7)* 39.4 (36.2–44.2)* 23.6 (20.0–28.6)
MIR (BR) 4 [3–4]* 0 [0] 4 [21] 12.4 (10.2–12.8)* 11.6 (9.8–14.4)* 13.6 (11.4–15.7)* 13.5 (11.2–17.6)* 7.5 (5.9–8.6)*
MIR (ST) 4 [3–4]* 0 [0] 2 [11] 8.4 (7.3–9.8)* 9.3 (7.3–10.7)* 10.2 (9.4–11.3)* 10.5 (8.9–14.3)* 5.6 (4.9–7.9)*
60% reduced dose
FBP 2 [2–3]* 13 [68] 19 [100] 97.5 (84.1–106.7)* 88.7 (77.4–120.8)* 103.1 (89.8–115.0)* 103.7 (85.6–111.1)* 42.2 (33.0–49.8)*
iDose4 3 [3–3] 0 [0] 6 [32] 40.6 (38.9–45.1)* 39.3 (35.8–48.1)* 46.2 (40.2–52.5)* 45.6 (38.3–49.5)* 27.4 (24.5–37.2)*
MIR (BR) 4 [3–4] 1 [5] 7 [37] 13.7 (11.2–15.6)* 12.9 (10.8–14.6)* 15.2 (13.1–17.4)* 14.2 (12.5–16.4)* 8.5 (7.3–11.7)*
MIR level 2 (ST) 3 [3–4]* 0 [0] 2 [5] 10.1 (8.3–12.0)* 9.2 (8.6–10.7)* 11.6 (10.1–13.3)* 10.2 (9.2–12.3)* 7.2 (5.3–10.5)*
80% reduced dose
FBP 1 [1–1]* 19 [100] 19 [100] 160.9 (136.0–187.6)* 168.7 (131.0–192.9)* 184.7 (152.8–203.3)* 165.6 (146.9–187.5)* 57.2 (36.8–63.2)*
iDose4 2 [2–3]* 11 [58] 17 [90] 47.4 (45.3–64.7) 51.0 (45.4–59.0) 50.6 (44.3–63.6) 51.8 (48.0–64.7) 33.4 (26.8–41.7)*
MIR (BR) 3 [3–3]* 4 [21] 14 [74] 15.9 (12.9–17.2)* 14.6 (12.3–17.8)* 17.1 (15.6–19.4)* 15.2 (13.9–19.1)* 9.8 (8.8–15.4)*
MIR (ST) 3 [2–3]* 6 [32] 13 [69] 12.4 (9.9–13.9)* 11.8 (10.3–14.7)* 14.4 (11.8–16.0)* 12.5 (10.5–15.7)* 9.2 (6.4–15.1)*
*Significant difference compared to the reference (p<0.0125)
FBP filtered back projection, HIR hybrid iterative reconstruction, MIR model-based iterative reconstruction, BR body routine, ST soft tissue, Obs
observer
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and low-dose CT acquisition with a radiation dose of
12.7 mSv and 1.6 mSv, respectively. The sensitivity at low
dose was 90% with a specificity of 99%. There were 102
stones present, of which 75% were smaller than 5 mm. No
IR was used. Fontarensky et al. [9] compared routine dose
acquisitions with hybrid IR (ASIR, GE Healthcare) to low-
dose acquisitions with model-based IR (MBIR, GE
Healthcare) at a radiation dose level of 8.8 mSv (10.9 mGy)
and 1.4 mSv (1.7 mGy), respectively. Both acquisitions were
made successively in the same patients. The diagnostic accu-
racy at low dose was excellent and objective and subjective
image quality were comparable. Also the detection of alterna-
tive diagnoses was not hampered at reduced dose. To our best
knowledge, only two studies investigated ultra-low-dose ac-
quisitions at submillisievert dose levels [10, 17]. In a study by
Glazer et al. [10], a split-dose design was used in which 52
patients received both a 80% dose scan and a 20% dose scan.
Radiation dose was 3.9 mSv (4.8 mGy) and 1.0 mSv (1.2
mGy), respectively, and MBIR was used for reconstruction.
Subjective and objective image quality were significantly low-
er at reduced dose, and the diagnostic accuracy decreased to a
sensitivity of 74% and a specificity of 77% for stones smaller
than 3 mm. In a similar study by McLaughlin and colleagues
[17], patients received a routine dose (4.4 mSv) and low-dose
(0.5 mSv) acquisition. The sensitivity decreased to 72% at low
dose, which was mainly caused by missed small stones. In
addition, several extra-urinary findings like gallstones and ap-
pendicitis were missed at low dose. The current study corrob-
orates those results and underscores that excessive radiation
dose reduction to submillisievert dose levels is not feasible in
an average adult due to a decrease in diagnostic accuracy. This
study also found that the decrease in sensitivity is caused by
small stones (<3 mm) that are missed, while larger stones
remain visible.
One of the disadvantages of IR often mentioned is the
longer reconstruction time compared to FBP [18]. This is
mainly a problem of MIR algorithms, while HIR results in
less than a minute delay compared to FBP [19]. The MIR
algorithm used in the current study, IMR, takes less than
5 min for the majority of the protocols according to the vendor
[20]. Amore recent study by Yuki et al. investigating chest CT
reported a reconstruction time within 3 min for all cases [21].
This delay is clinically acceptable for CTscans for urolithiasis.
However, longer reconstruction times up to an hour have been
reported for other MIR algorithms [22–24].
The main strength of the current study is the within-patient
design using four different dose levels to investigate the
achievable radiation dose reduction. Not only the accuracy
for stone detection was researched, but also the possibility to
diagnose extra-urinary tract pathology, which is important in
clinical practice. Furthermore, both hybrid andmore advanced
model-based IRwere investigated and, to our best knowledge,
this is the first study using IMR for this purpose. This study
has several limitations. First, a relatively small sample size
was used because the study participants were exposed to four
CTscans. However, compared to other studies a large number
of stones was present. Second, the IR algorithms of only one
vendor were investigated. Lastly, the effect of dose reduction
and IR on the stone size was not investigated. A previous
study showed that MIR might overestimate the stone density
and size compared to HIR [25]. It was, however, not clear if
this was truly an overestimation, or if HIR underestimated the
stone size. Future studies using a phantom with stones with
known density and size should be performed to demonstrate
this.
In conclusion, the radiation dose for the assessment of uro-
lithiasis can be reduced by 40% (HIR) to 60% (MIR) without
affecting diagnostic performance or image quality. Further
dose reduction leads to decreased sensitivity for small stones
and hampers the assessment of extra-urinary tract pathology.
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